Taijyu Satoh

1.5k total citations
37 papers, 723 citations indexed

About

Taijyu Satoh is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Taijyu Satoh has authored 37 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 18 papers in Cardiology and Cardiovascular Medicine and 12 papers in Molecular Biology. Recurrent topics in Taijyu Satoh's work include Pulmonary Hypertension Research and Treatments (22 papers), Cardiovascular Function and Risk Factors (10 papers) and Signaling Pathways in Disease (6 papers). Taijyu Satoh is often cited by papers focused on Pulmonary Hypertension Research and Treatments (22 papers), Cardiovascular Function and Risk Factors (10 papers) and Signaling Pathways in Disease (6 papers). Taijyu Satoh collaborates with scholars based in Japan, United States and Norway. Taijyu Satoh's co-authors include Kimio Satoh, Hiroaki Shimokawa, Satoshi Miyata, Junichi Omura, Nobuhiro Kikuchi, Ryo Kurosawa, Shinichiro Sunamura, Masamichi Nogi, Nobuhiro Yaoita and Mohammad Abdul Hai Siddique and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Circulation Research.

In The Last Decade

Taijyu Satoh

33 papers receiving 717 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Taijyu Satoh Japan 16 273 272 228 97 89 37 723
Junichi Omura Japan 17 316 1.2× 304 1.1× 239 1.0× 115 1.2× 96 1.1× 33 749
Masamichi Nogi Japan 14 214 0.8× 245 0.9× 178 0.8× 90 0.9× 83 0.9× 16 586
Ikuko Nakamura Japan 10 140 0.5× 210 0.8× 222 1.0× 89 0.9× 106 1.2× 19 699
Naifeng Liu China 18 113 0.4× 377 1.4× 172 0.8× 157 1.6× 135 1.5× 51 878
Xiaoxu Zhou China 17 110 0.4× 424 1.6× 127 0.6× 72 0.7× 103 1.2× 46 992
Motoi Kobayashi Japan 15 359 1.3× 525 1.9× 157 0.7× 213 2.2× 123 1.4× 21 1.1k
Liam A. Hurst United Kingdom 6 154 0.6× 251 0.9× 86 0.4× 56 0.6× 54 0.6× 6 521
Qianqian Zhang China 17 313 1.1× 408 1.5× 74 0.3× 160 1.6× 82 0.9× 53 801
M. Eugenia Burgos Chile 15 98 0.4× 414 1.5× 158 0.7× 91 0.9× 109 1.2× 24 1.1k
Eva Tarantino Italy 15 160 0.6× 194 0.7× 81 0.4× 70 0.7× 45 0.5× 18 596

Countries citing papers authored by Taijyu Satoh

Since Specialization
Citations

This map shows the geographic impact of Taijyu Satoh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taijyu Satoh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taijyu Satoh more than expected).

Fields of papers citing papers by Taijyu Satoh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taijyu Satoh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taijyu Satoh. The network helps show where Taijyu Satoh may publish in the future.

Co-authorship network of co-authors of Taijyu Satoh

This figure shows the co-authorship network connecting the top 25 collaborators of Taijyu Satoh. A scholar is included among the top collaborators of Taijyu Satoh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taijyu Satoh. Taijyu Satoh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamada, Yusuke, Taijyu Satoh, Saori Yamamoto, et al.. (2026). Pathogenesis of Pulmonary Artery Remodeling: TGF-Beta Signaling and Inhibin Subunit Beta A in Group 1 and 2 Pulmonary Hypertension. Arteriosclerosis Thrombosis and Vascular Biology. 46(3). e322506–e322506.
2.
Satoh, Taijyu, Saori Yamamoto, Yusuke Yamada, et al.. (2025). Long‐Term Prognostic and Hemodynamic Outcomes of Intensive Immunosuppressive Therapy in Patients With Pulmonary Arterial Hypertension Associated With Connective Tissue Disease. International Journal of Rheumatic Diseases. 28(10). e70431–e70431.
3.
Satoh, Taijyu, Satoshi Higuchi, Kotaro Nochioka, et al.. (2024). Impact of Sodium‐Glucose Co‐Transporter‐2 Inhibitors on Exercise‐Induced Pulmonary Hypertension. Pulmonary Circulation. 14(4). e70026–e70026. 2 indexed citations
4.
Suzuki, Hideaki, Takumi Inoue, Marina Arai, et al.. (2024). Evaluating Haemodynamic Changes: Vericiguat in Patients with Heart Failure with Reduced Ejection Fraction. ESC Heart Failure. 11(4). 2451–2454. 9 indexed citations
5.
Satoh, Taijyu, Kotaro Nochioka, Saori Yamamoto, et al.. (2024). Improving Balloon Pulmonary Angioplasty Through Target Endpoint Optimization With Pressure Catheter and Angiographic Lung Perfusion. JACC: Cardiovascular Interventions. 17(20). 2394–2407. 1 indexed citations
6.
Satoh, Taijyu, Nobuhiro Yaoita, Kotaro Nochioka, et al.. (2023). Inhaled Nitric Oxide Testing in Predicting Prognosis in Pulmonary Hypertension Due to Left-Sided Heart Diseases. ESC Heart Failure. 10(6). 3592–3603. 5 indexed citations
7.
Ota, Hideki, Nobuhiro Yaoita, Hiroki Kamada, et al.. (2022). Update on the roles of imaging in the management of chronic thromboembolic pulmonary hypertension. Journal of Cardiology. 81(3). 297–306. 9 indexed citations
8.
Yaoita, Nobuhiro, Kimio Satoh, Taijyu Satoh, et al.. (2020). Identification of the Novel Variants in Patients With Chronic Thromboembolic Pulmonary Hypertension. Journal of the American Heart Association. 9(21). e015902–e015902. 10 indexed citations
9.
Satoh, Taijyu, Ling Wang, Andrea R. Levine, et al.. (2020). SGLT2 Inhibition Ameliorates Exercise-Induced Pulmonary Hypertension (EIPH) in Heart Failure with Preserved Ejection Fraction. A7671–A7671. 2 indexed citations
10.
Kozu, Katsuya, Kimio Satoh, Tatsuo Aoki, et al.. (2019). Cyclophilin A as a biomarker for the therapeutic effect of balloon angioplasty in chronic thromboembolic pulmonary hypertension. Journal of Cardiology. 75(4). 415–423. 3 indexed citations
11.
Wang, Ling, Jonas T. Sertório, Taijyu Satoh, et al.. (2019). Explore the Mechanisms for the Development of Post-Splenectomy Pulmonary Hypertension in a Mouse Model of β-Thalassemia. A5041–A5041. 1 indexed citations
12.
Satoh, Kimio, Tôru Shimizu, Shohei Ikeda, et al.. (2019). Identification of Adipsin as a Novel Prognostic Biomarker in Patients With Coronary Artery Disease. Journal of the American Heart Association. 8(23). e013716–e013716. 38 indexed citations
13.
Satoh, Kimio, Taijyu Satoh, Nobuhiro Yaoita, & Hiroaki Shimokawa. (2019). Recent Advances in the Understanding of Thrombosis. Arteriosclerosis Thrombosis and Vascular Biology. 39(6). e159–e165. 22 indexed citations
14.
Nogi, Masamichi, Kimio Satoh, Shinichiro Sunamura, et al.. (2018). Small GTP-Binding Protein GDP Dissociation Stimulator Prevents Thoracic Aortic Aneurysm Formation and Rupture by Phenotypic Preservation of Aortic Smooth Muscle Cells. Circulation. 138(21). 2413–2433. 36 indexed citations
15.
Satoh, Taijyu, et al.. (2018). A Leadless Pacemaker Which Became Encapsulated Only Two Months after Placement. Internal Medicine. 57(20). 3053–3054. 7 indexed citations
16.
Satoh, Taijyu, Kimio Satoh, Nobuhiro Yaoita, et al.. (2017). Activated TAFI Promotes the Development of Chronic Thromboembolic Pulmonary Hypertension. Circulation Research. 120(8). 1246–1262. 40 indexed citations
17.
Kudo, Shun, Kimio Satoh, Masamichi Nogi, et al.. (2016). SmgGDS as a Crucial Mediator of the Inhibitory Effects of Statins on Cardiac Hypertrophy and Fibrosis. Hypertension. 67(5). 878–889. 29 indexed citations
18.
Omura, Junichi, Kimio Satoh, Nobuhiro Kikuchi, et al.. (2016). Protective Roles of Endothelial AMP-Activated Protein Kinase Against Hypoxia-Induced Pulmonary Hypertension in Mice. Circulation Research. 119(2). 197–209. 87 indexed citations
19.
Yaoita, Nobuhiro, Kimio Satoh, Taijyu Satoh, et al.. (2016). Thrombin-Activatable Fibrinolysis Inhibitor in Chronic Thromboembolic Pulmonary Hypertension. Arteriosclerosis Thrombosis and Vascular Biology. 36(6). 1293–1301. 35 indexed citations
20.
Narisawa, K., et al.. (1982). Clinical and biochemical findings on a child with multiple biotin‐responsive carboxylase deficiencies. Journal of Inherited Metabolic Disease. 5(2). 67–68. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Junichi Omura Breakdown of academic impact, for papers by Masamichi Nogi Breakdown of academic impact, for papers by Ikuko Nakamura Breakdown of academic impact, for papers by Naifeng Liu Breakdown of academic impact, for papers by Xiaoxu Zhou Breakdown of academic impact, for papers by Motoi Kobayashi Breakdown of academic impact, for papers by Liam A. Hurst Breakdown of academic impact, for papers by Qianqian Zhang Breakdown of academic impact, for papers by M. Eugenia Burgos Breakdown of academic impact, for papers by Eva Tarantino
Rankless by CCL
2026